About the journal
Seminars in Oncology is a journal published by Elsevier BV in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,660 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1532-8708 · 0093-7754
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 3,660 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/seminars-in-oncology
Index listings
- MEDLINE · 1977-01-01
- Indexing
- MEDLINE
- APC
- 3,660 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 102 days received→accepted — computed from PubMed (n=97)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
4270
Last recorded publication year
2026
h-index
147
i10-index
2132
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 74%
- ORCID iDs in current deposits
- 49%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 0420432
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
Show all subjects (50)
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Marriage and Sexual Relationships
- Marriage and Sexual Relationships
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- CAR-T cell therapy research
- CAR-T cell therapy research
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Bone health and treatments
- Bone health and treatments
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ